User blogs

The global Hemophilia Market was valued at USD 13.6 billion in 2023 and is projected to reach USD 22.50 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.5% over the forecast period from 2024 to 2031. The rising incidence of hemophilia, coupled with increased awareness, the adoption of innovative therapies, and advancements in gene treatments, is driving significant growth in the market.Market OverviewHemophilia is a rare genetic bleeding disorder caused by a deficiency in clotti... more